GSK-3ALPHA IN HUNTINGTON’S DISEASE (ID 1797)

Presenter
Authors
Gallery Display
Onsite Oral and Gallery PDF

Previous ePoster
EXAMINATION OF WHITE MATTER TRACTS IN PROGRESSIVE SUPRANUCLEAR PALSY VARIANTS BY DIFFUSION TENSOR IMAGING PARAMETERS, CONNECTOMICS, AND BRAIN NETWORK ANALYTICS (ID 1795)

Next ePosters
RELATIONSHIP BETWEEN AMYLOID-PET BINDING, WHITE MATTER MICROSTRUCTURE AND COGNITION IN A MIXED COHORT OF SMALL VESSEL DISEASE AND ALZHEIMER’S PATHOLOGY (ID 1816)
AMYLOID SEEDING EMERGES AS A POTENTIAL TARGET FOR THE TREATMENT OF AMYLOIDOSIS (ID 2222)
SYNAPTIC ESTROGEN RECEPTOR ALPHA IMPROVES E46K-AMPLIFIED 3K ALPHA-SYNUCLEIN NEUROPATHOLOGY AND PHENOTYPES IN MICE (ID 2225)
FEASIBILITY AND SAFETY OF SIMULTANEOUSLY IMPLANTING AUTOLOGOUS REGENERATIVE PERIPHERAL NERVE TISSUE TO THE NUCLEUS BASALIS OF MEYNERT AND SUBSTANTIA NIGRA IN PATIENTS WITH PARKINSON’S DISEASE (ID 2227)
APOLIPOPROTEIN L1 IS INCREASED IN FRONTOTEMPORAL LOBAR DEGENERATION POST-MORTEM BRAIN TISSUE BUT NOT IN CEREBROSPINAL FLUID (ID 2231)
MITOCHONDRIAL DEFECTS IN ALZHEIMER’S DISEASE: MECHANISMS AND THERAPEUTIC APPROACHES (ID 2235)
FAMILIAL ALZHEIMER'S DISEASE NEUROPROGENITOR CELLS DISPLAY PRONOUNCED MITOCHONDRIAL METABOLISM ALTERATIONS (ID 2236)
OXIDATIVE STRESS TRIGGERS BASAL FOREBRAIN NEURODEGENERATION BY IMPAIRING PRONGF AXONAL TRANSPORT (ID 2237)
INVOLVEMENT OF RNA MODIFICATIONS AND CORRESPONDING WRITER ENZYMES AT A SPECIFIC MITOCHONDRIAL MRNA SITE IN ALZHEIMER'S DISEASE (ID 2239)
NEURONS ISOLATED FROM A53T SYNUCLEIN MICE DISPLAY DEFICITS IN SYNAPTIC DENISTY AND MITOCHONDRIAL FUNCTION THAT CAN BE ATTENUATED BY NRF2 ACTIVATION (ID 2240)